↓ Skip to main content

Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Overview of attention for article published in Breast Cancer Research, March 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
2 news outlets

Citations

dimensions_citation
242 Dimensions

Readers on

mendeley
81 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]
Published in
Breast Cancer Research, March 2006
DOI 10.1186/bcr1384
Pubmed ID
Authors

Trevor Powles, Alexander Paterson, Eugene McCloskey, Phil Schein, Bobbi Scheffler, Alwynne Tidy, Sue Ashley, Ian Smith, Lars Ottestad, John Kanis

Abstract

Experimental and clinical data show that the oral bisphosphonate clodronate (Bonefos) can inhibit tumor-induced osteoclastic bone resorption. This randomized, double-blind, placebo-controlled, multicenter trial was designed to determine if the addition of oral clodronate to standard treatment for primary operable breast cancer could reduce the subsequent occurrence of bone metastases and thereby improve overall survival.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 1%
Unknown 80 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 17%
Researcher 14 17%
Student > Ph. D. Student 14 17%
Other 8 10%
Student > Bachelor 7 9%
Other 9 11%
Unknown 15 19%
Readers by discipline Count As %
Medicine and Dentistry 33 41%
Agricultural and Biological Sciences 10 12%
Psychology 5 6%
Nursing and Health Professions 4 5%
Biochemistry, Genetics and Molecular Biology 3 4%
Other 4 5%
Unknown 22 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2019.
All research outputs
#2,485,356
of 25,373,627 outputs
Outputs from Breast Cancer Research
#240
of 2,052 outputs
Outputs of similar age
#5,277
of 85,642 outputs
Outputs of similar age from Breast Cancer Research
#2
of 12 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 85,642 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.